Information  X 
Enter a valid email address

Scientific Dig Imag (SDI)

  Print      Mail a friend

Friday 20 September, 2019

Scientific Dig Imag

Date of Annual General Meeting

RNS Number : 1537N
Scientific Digital Imaging Plc
20 September 2019
 

Scientific Digital Imaging plc

("SDI", the "Company" or the "Group")

Date of Annual General Meeting

 

Scientific Digital Imaging plc, the AIM quoted group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, announces that its Annual General Meeting will take place at the offices of Mills & Reeve LLP at Botanic House, 100 Hills Road, Cambridge CB2 1PH at 11.00 a.m. on Wednesday 25 September 2019.

A copy of the notice of AGM, as sent to shareholders, is available on the Company's website at www.scientificdigitalimaging.com/investors/reports-presentations/.

 

FOR FURTHER INFORMATION

Scientific Digital Imaging plc

Ken Ford, Chairman

Mike Creedon, Chief Executive Officer

Jon Abell, Chief Financial Officer

www.scientificdigitalimaging.com

 

01223 727144

 

 

finnCap Ltd           

Ed Frisby/Kate Washington - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

020 7220 0500

 

 

JW Communications

Julia Wilson - Investor & Public Relations

 

07818 430 877

 

About SDI

Scientific Digital Imaging plc ("SDI") designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation. SDI operates through its company divisions: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries and Fistreem.

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NOAEAFNEASDNEFF

a d v e r t i s e m e n t